Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response
Diabetes & Metabolism Journal · 2024
DOI: 10.4093/dmj.2024.0382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, 2024. Verfasst von Nikhil Kirtipal und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Precision Medicine, Systems Biology. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science ICT, National Research Foundation of Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
The human gut microbiota is increasingly recognized as a pivotal factor in diabetes management, playing a significant role in the body’s response to treatment. However, it is important to understand that long-term usage of medicines like metformin and other diabetic treatments can result in problems, gastrointestinal discomfort, and dysbiosis of the gut flora. Advanced sequencing technologies have improved our understanding of the gut microbiome’s role in diabetes, uncovering complex interactions between microbial composition and metabolic health. We explore how the gut microbiota affects glucose metabolism and insulin sensitivity by examining a variety of -omics data, including genomics, transcriptomics, epigenomics, proteomics, metabolomics, and metagenomics. Machine learning algorithms and genome-scale modeling are now being applied to find microbiological biomarkers associated with diabetes risk, predicted disease progression, and guide customized therapy. This study holds promise for specialized diabetic therapy. Despite significant advances, some concerns remain unanswered, including understanding the complex relationship between diabetes etiology and gut microbiota, as well as developing user-friendly technological innovations. This mini-review explores the relationship between multiomics, precision medicine, and machine learning to improve our understanding of the gut microbiome’s function in diabetes. In the era of precision medicine, the ultimate goal is to improve patient outcomes through personalized treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Förderung
- Ministry of Science ICT
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Korea National Institute of Health
- GIST Research Institute
Zitieren
APA
Kirtipal, N., Seo, Y., Son, J., & Lee, S. (2024). Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2024.0382
Vancouver
Kirtipal N, Seo Y, Son J, Lee S. Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2024.0382
BibTeX
@article{Kirtipal2024,
author = {Kirtipal, Nikhil and Seo, Youngchang and Son, Jangwon and Lee, Sunjae},
title = {Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response},
journal = {Diabetes & Metabolism Journal},
year = {2024},
doi = {10.4093/dmj.2024.0382}
}
EUVIMED